Aims and Scope
Vaccine is a peer-reviewed medical journal, published by Elsevier. It is targeted towards medical professionals who are interested in vaccines and vaccination. The official journal of the Edward Jenner Society and the Japanese Society for Vaccinology, Vaccine describes itself as "an interface between academics, those in research and development, and workers in the field", covering topics "rang[ing] from basic research through to applications, safety[,] and legislation." As of 2020, Gregory A. Poland is Vaccine's editor-in-chief.
Key Metrics
6.7
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
5 - 10
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
205
H index
H-Index
Journal's h-index reflects the collective citation impact of the authors publishing in the journal. The h-index is defined as the maximum value of h such that the given journal has published at least h papers that have each been cited at least h times.
0.86
5-Year SI
5-year SI
- 0.87 2-year SI
- 0.88 Lifetime SI
Scite Index
Scite Index
scite Index is the ratio of citations supporting research which is published in the journal to sum of citations either supporting or contrasting the research published in the journal for the same time period. Minimum 100 supporting citations required.
Q1
Molecular Medicine
SJR
- Q1 Molecular Medicine
- Q1 Infectious Diseases
- Q1 Veterinary (miscellaneous)
- Q1 Immunology and Microbiology (miscellaneous)
- Q1 Public Health, Environmental and Occupational Health
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
1.4
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
4 Mo
Time to Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time To Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
% of papers by time taken from submission to publication
0 to 3 months
25%
4 to 6 months
45%
7 to 9 months
19%
Above 9 months
10%
Did you find this useful?
Thank you for your feedback.
Topics Covered
- Disease
- Virus
- Immunization
- Vaccine strain
- Influenza vaccine
- Streptococcus pneumoniae
- Supply chain
- Economic evaluation
- Conjugate vaccine
- Confidence interval
- Public health
- Fusion protein
- Randomized controlled trial
- Pandemic
- Cholera
- Human papillomavirus
- Vaccine efficacy
- Antigen
- Vaccination coverage
- Escherichia coli
Journal Specifications
| Overview | |
| Publisher | ELSEVIER SCI LTD |
| Language | English |
| Frequency | Weekly |
| General Details | |
| Language | English |
| Frequency | Weekly |
| Publication Start Year | 1983 |
| Publisher URL | Visit website |
| Website URL | Visit website |
Planning to publish in Vaccine ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Human papillomavirus vaccination coverage among adolescent boys and girls in the United States: A birth year cohort analysis of the National Immunization Survey-Teen, 2016–2022.
- 1 Jan 25
- Vaccine
-
Full paper
Safety and immunogenicity of the Ad26/protein preF RSV vaccine in adults aged 18 to 59 years with and without at-risk comorbidities for severe respiratory syncytial virus disease: A phase 3, randomized, controlled, immunobridging trial
- 1 Jan 25
- Vaccine
-
Full paper
Klebsiella pneumoniae bioconjugate vaccine functional durability in mice
- 1 Jan 25
- Vaccine
-
Full paper
Live-attenuated vaccine failure after liver transplantation: A 20-year cohort study
- 1 Jan 25
- Vaccine
-
Full paper
Exposure to objective/sensationalist information moderates associations between psychological factors and COVID-19 anti-vaccination attitudes: An experimental study
- 1 Jan 25
- Vaccine
-
Full paper
Vaccine efficacy induced by 2020-2021 seasonal influenza-derived H3N1 virus-like particles co-expressing M2e5x or N2
- 1 Jan 25
- Vaccine
Scite analysis
Powered by scite_
30.8k articles received 724k citations see all
- 31,784 Supporting
- 669,573 Mentioning
- 4,235 Contrasting
Editorial notices
- 5 Retractions
- 19 Withdrawals
- 0 Corrections
- 84 Errata
- 2 Expression of Concern
FAQs
How long has Vaccine been actively publishing?
Vaccine has been in operation since 1983 till date.
What is the publishing frequency of Vaccine ?
Vaccine published with a Weekly frequency.
How many articles did Vaccine publish last years ?
In 2023, Vaccine published 934 articles.
What is the eISSN & pISSN for Vaccine ?
For Vaccine,eISSN is 1873-2518 and pISSN is0264-410X.
What is Citescore for Vaccine ?
Citescore for Vaccine is 6.7.
What is H index for Vaccine ?
H index for Vaccine is 205.
What is SNIP score for Vaccine ?
SNIP score for Vaccine is 1.4.
What is the SJR for Vaccine ?
SJR for Vaccine is Q1.
Who is the publisher of Vaccine ?
ELSEVIER SCI LTD is the publisher of Vaccine.